ÂÜÀòÂÒÂ×

NG

Nenad Grmusa

Director at Ambys Medicines

Nenad Grmusa leads the R&D Strategy and External Innovation (RSEI) group at Takeda. In this role, he oversees all external research and development activities including strategic venture investments, academic alliances, R&D collaborations, and spinouts. He is also responsible for R&D Finance and Portfolio Strategy, innovative R&D business, and venture investment models, and divestiture strategies for non-core assets.

Previously, Mr. Grmusa served as Head of the Center for External Innovation (CEI) and R&D Portfolio & Investment Strategy at Takeda, where he supported the Head of R&D in managing Takeda’s diverse pipeline from early discovery to commercial life cycle management. Mr. Grmusa has 20 years of experience in R&D finance, financial planning and analysis, and pharmaceutical portfolio management.